tiprankstipranks
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Technical Analysis

Compare
44 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Biosyent Inc’s (RX) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Biosyent Inc is a Sell.
Biosyent Inc’s (RX) 20-Day exponential moving average is 11.07, while Biosyent Inc’s (RX) share price is C$11.09, making it a Buy.
Biosyent Inc’s (RX) 50-Day exponential moving average is 11.11, while Biosyent Inc’s (RX) share price is C$11.09, making it a Sell.

Biosyent (RX) Pivot Points

Feb 23, 2025, 03:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.02
11.03
11.07
11.08
11.12
11.13
11.17
Fibonacci
11.03
11.05
11.06
11.08
11.10
11.11
11.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biosyent (RX) Moving Averages

Feb 23, 2025, 03:42 PM
Period
Simple
Exponential
MA5
11.05Buy
11.07Buy
MA10
11.07Buy
11.06Buy
MA20
11.05Buy
11.07Buy
MA50
11.22Sell
11.11Sell
MA100
11.17Sell
10.99Buy
MA200
10.51Buy
10.36Buy
Biosyent Inc’s (RX) 10-Day exponential moving average is 11.06, while Biosyent Inc’s (RX) share price is C$11.09, making it a Buy.
Biosyent Inc’s (RX) 100-Day exponential moving average is 10.99, while Biosyent Inc’s (RX) share price is C$11.09, making it a Buy.
Biosyent Inc’s (RX) stock price is C$11.09 and Biosyent Inc’s (RX) 50-day simple moving average is 11.22, creating a Sell signal.
Biosyent Inc’s (RX) stock price is C$11.09 and Biosyent Inc’s (RX) 100-day simple moving average is 11.17, creating a Sell signal.
Biosyent Inc’s (RX) stock price is C$11.09 and Biosyent Inc’s (RX) 200-day simple moving average is 10.51, creating a Buy signal.

Biosyent (RX) Technical Indicators

Feb 23, 2025, 03:42 PM
Name
Value
Implied Action
RSI (14)
50.65
Neutral
STOCH (9,6)
87.04
Sell
STOCHRSI (14)
78.33
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
17.71
Buy
Williams %R
-15.00
Sell
CCI (14)
23.65
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
54.38
Neutral
ROC
0.82
Buy
Biosyent Inc’s (RX) Relative Strength Index (RSI) is 50.65, creating a Neutral signal.
Biosyent Inc’s (RX) Trend Strength Indicator (ADX) is 17.71, creating a Buy signal.
Biosyent Inc’s (RX) Commodity Channel Index (CCI) is 23.65, creating a Neutral signal.
Biosyent Inc’s (RX) Price Rate of Change (ROC) is 0.82, creating a Buy signal.

FAQ

Is RX a Buy, Hold, or Sell?
Based on RX’s technical indicators, RX is a Buy.
    What is RX’s RSI (14)?
    RX’s RSI (14) is 50.65, which suggests RX is a Neutral.
      What is RX’s MACD?
      RX’s MACD is -0.02, which suggests RX is a Sell.
        What is RX’s 5-day moving average?
        RX’s 5-day moving average is 11.05, which suggests RX is a Buy.
          What is RX’s 20-day moving average?
          RX 20-day moving average is 11.05, which suggests RX is a Buy.
            What is RX’s 50-day moving average?
            RX’s 50-day moving average is 11.22, which suggests RX is a Sell.
              What is RX’s 200-day moving average?
              RX’s 200-day moving average is 10.51, which suggests RX is a Buy.
                What is RX’s Williams % R (14)?
                RX’s Williams % R (14) is -15.00, which suggests RX is a Sell.
                  What is RX’s CCI (14)?
                  RX’s CCI (14) is 23.65, which suggests RX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis